IL33 and neoplasm: Kwon et al. demonstrated that Th2 cytokines might create an unfavorable TME for tumor growth independent of adaptive immunity and found that local production of IL-33 established a high number of type 2 innate lymphoid cells with potent antitumor activity 32.